While the earnings result for many companies is being released, investors are closely watching the following three stocks that may have a decent performance being reported.
Bapcor Limited (ASX: BAP) deals in accessories, automotive aftermarket parts, automotive equipment and services and the stock was trading at a current market price of $7.1 and has seen a daily price change of $0.12 or a percentage change of 1.719%. The stock has undergone a performance change of 25.99% over the past 12 months. The speculations are that Bapcor is likely a candidate to acquire the Kmart Tyre and Auto business. As evidenced by its acquisitions that have been made since its ASX listing in 2014, Bapcor has a very disciplined acquisition process. Also, the Hellaby Automotive operating segment of the company will not be reported as a separate segment. Meanwhile, BAP has divested TRS Tyre and Wheel Business in New Zealand. The group will report FY18 result on August 22, 2018.
CSL Limited (ASX: CSL), the health care giant, saw its stock at a current market price of $200.61 and has seen a daily price change of -$0.99 or a percentage change of -0.49%. It is trading near its 52-week high. The stock has undergone a performance change of 58.79% over the past 12 months. CSL has however, rallied 43% since the start of the year and has been the second highest contributor to the S&P/ASX 200 Index in 2017-18. The group lifted its profit guidance lately to US $1,680 to $1,710 million at constant currency. It is expected that the group will be able to deliver as per the guidance at the back of positive developments for its therapy products.
Altium Limited (ASX: ALU), the information technology player has witnessed a great run-up in stock price in the past one year. The stock was trading at a current market price of $20.690 and has seen a daily price change of $0.27 or a percentage change of 1.322%. The stock has undergone a performance change of 135.04% over the past 12 months. The company will announce its fiscal 2018 full year results on August 21, 2018. The company has seen a year on year revenue growth of 18.42% from $93.70 million to $110.96 million, while net income improved from $23.02 million to $28.08 million which is up by 21.97%. Given the performance so far, the stock looks one to watch with regards to the earnings result.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a company’s prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
Join Our Discussion
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
6 Cannabis Stocks under Investor’s Limelight…
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report
